38091187

https://pubmed.ncbi.nlm.nih.gov/38091187

Perioperative immunotherapy is now an integral component of care for early-stage non-small cell lung cancer (NSCLC), although it should be avoided in select cases and may not yet show overall survival benefits, which are expected to emerge as data mature.